Two Sigma Securities »

Cytomed Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Cytomed Therapeutics (GDTC) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Cytomed Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomed Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomed Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $16k 12k 1.34

More positions owned by Two Sigma Securities

Ishares Tr Iboxx Hi Yd Etf (HYG)
Microsoft Corporation (MSFT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Core Msci Total (IXUS)
Oracle Corporation (ORCL)
Ishares Tr Core Univrsl Usd (IUSB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Broad Usd High (USHY)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)

View all positions for Two Sigma Securities

Top funds holding Cytomed Therapeutics

Susquehanna International
Two Sigma Securities
Intl Fcstone
UBS Group
Advisor Group Holdings

View all funds holding Cytomed Therapeutics